Genomic predictors of outcome and treatment response in breast cancer.
about
The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysisProteomics of ovarian cancer: functional insights and clinical applicationsRenal cell carcinoma: where will the state-of-the-art lead us?Proteomics and ovarian cancer: integrating proteomics information into clinical careHuman bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis.Proteomics as a guiding tool for more effective personalized therapy.Analysis of gene expression profiles as a tool to uncover tumor markers of liver cancer progression in a rat model.The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cellsPathological complete response in younger and older breast cancer patientsHER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions.A tale of mice and (wo)men: development of and insights from an "all human" animal model of breast cancer metastasis to boneThe metastasis-promoting roles of tumor-associated immune cellsIntegrated genomic analysis of breast cancers.Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profilingEmerging biomarkers in breast cancer care.Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.Microfluidic strategies applied to biomarker discovery and validation for multivariate diagnostics.BIM, PUMA, and the achilles' heel of oncogene addiction.Wenshen Zhuanggu formula effectively suppresses breast cancer bone metastases in a mouse Xenograft model.
P2860
Q26861418-0794BBEB-33B9-4EAC-94D6-F14C6A18710DQ28082632-D44E218F-9B4B-48F1-81CE-C57524C06126Q34003335-8396F67E-EAEB-4A87-9B9D-02BE5E3C4AE5Q34126627-9F130B41-55A0-445D-B118-585B4D143AD7Q34473242-FAD185D9-EF3A-41F5-BC83-AF17103F31A0Q34480451-A6E53C52-D1CA-457C-AC43-5FFAD6F48520Q35180104-29E0A343-DB27-4ADE-992B-1B19A3579647Q35931795-DA9FC5AD-1EC8-4881-A80A-867647EE0580Q35990463-F77537F9-7B7F-42E9-9454-0B50606B8B86Q36244056-EF071CDA-DEE3-4800-B7B0-12148A662608Q36519704-11C5D038-490C-4C59-AB32-6554B04C324AQ36972016-98C8C6C4-EC18-4331-A863-D57A3541F3DDQ37181531-6BF711A4-E17B-45B0-BF8A-4D7A45C7C467Q37458486-BC6362ED-144D-4D67-A336-E398EF74F559Q37779305-286C2157-A2DB-4673-BC6C-60A822DDE003Q37800444-A525D7F8-1EC6-4F2D-9978-E468A435667FQ37943855-59B45BF0-888B-4FE2-8AC6-DC5BA34CD654Q38093430-5814CBAA-C609-4AD9-A649-1675F96E6FD5Q47792012-3337384D-A6DE-4809-A938-783383C664E8
P2860
Genomic predictors of outcome and treatment response in breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genomic predictors of outcome and treatment response in breast cancer.
@en
Genomic predictors of outcome and treatment response in breast cancer.
@nl
type
label
Genomic predictors of outcome and treatment response in breast cancer.
@en
Genomic predictors of outcome and treatment response in breast cancer.
@nl
prefLabel
Genomic predictors of outcome and treatment response in breast cancer.
@en
Genomic predictors of outcome and treatment response in breast cancer.
@nl
P2860
P356
P1476
Genomic predictors of outcome and treatment response in breast cancer.
@en
P2093
Angela Demichele
P2860
P2888
P356
10.1007/BF03256317
P577
2009-01-01T00:00:00Z